These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 39012199)

  • 1. Optimization of atorvastatin and quercetin-loaded solid lipid nanoparticles using Box-Behnken design.
    Lalchandani DS; Chenkual L; Sonpasare K; Rajdev B; Naidu V; Chella N; Porwal PK
    Nanomedicine (Lond); 2024 Jul; 19(17):1541-1555. PubMed ID: 39012199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer.
    Chaudhuri A; Naveen Kumar D; Kumar D; Kumar Agrawal A
    Eur J Pharm Biopharm; 2024 Aug; 201():114386. PubMed ID: 38950717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
    Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
    Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation optimization, characterization, and evaluation of in vitro cytotoxic potential of curcumin loaded solid lipid nanoparticles for improved anticancer activity.
    Rompicharla SVK; Bhatt H; Shah A; Komanduri N; Vijayasarathy D; Ghosh B; Biswas S
    Chem Phys Lipids; 2017 Nov; 208():10-18. PubMed ID: 28842128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Mitoxantrone-Loaded Quercetin Nanoparticles for Breast Cancer Therapy with Potential for Synergism with Bioactive Natural Products.
    Alkhaldi O; Abusulieh S; Abusara OH; Sunoqrot S
    Int J Pharm; 2024 Nov; 665():124674. PubMed ID: 39245083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization, and optimization of altretamine-loaded solid lipid nanoparticles using Box-Behnken design and response surface methodology.
    Gidwani B; Vyas A
    Artif Cells Nanomed Biotechnol; 2016; 44(2):571-80. PubMed ID: 25363752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin Solid Lipid Nanoparticles as a Promising Approach for Dermal Delivery and an Anti-inflammatory Agent.
    Shahraeini SS; Akbari J; Saeedi M; Morteza-Semnani K; Abootorabi S; Dehghanpoor M; Rostamkalaei SS; Nokhodchi A
    AAPS PharmSciTech; 2020 Sep; 21(7):263. PubMed ID: 32978691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic approach for the formulation and optimization of atorvastatin loaded solid lipid NANOAPARTICLES using response surface methodology.
    Sarangi B; Jana U; Sahoo J; Mohanta GP; Manna PK
    Biomed Microdevices; 2018 Jun; 20(3):53. PubMed ID: 29946758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
    Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
    Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pomegranate extract-loaded solid lipid nanoparticles: design, optimization, and in vitro cytotoxicity study.
    Badawi NM; Teaima MH; El-Say KM; Attia DA; El-Nabarawi MA; Elmazar MM
    Int J Nanomedicine; 2018; 13():1313-1326. PubMed ID: 29563789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of biocompatible copolymeric micelles as a carrier of atorvastatin and rosuvastatin for potential anticancer activity study.
    Hamidreza Kheiri M; Alimohammadi N; Danafar H
    Pharm Dev Technol; 2019 Mar; 24(3):303-313. PubMed ID: 29741465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation-optimization of solid lipid nanocarrier system of STAT3 inhibitor to improve its activity in triple negative breast cancer cells.
    Pindiprolu SKSS; Chintamaneni PK; Krishnamurthy PT; Ratna Sree Ganapathineedi K
    Drug Dev Ind Pharm; 2019 Feb; 45(2):304-313. PubMed ID: 30348020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of quality-by-design approach to optimize diallyl disulfide-loaded solid lipid nanoparticles.
    Talluri SV; Kuppusamy G; Karri VV; Yamjala K; Wadhwani A; Madhunapantula SV; Pindiprolu SS
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):474-488. PubMed ID: 27112220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel resveratrol smart lipids; design, formulation, and biological evaluation of anticancer activity.
    Diab RF; Abdelghany TM; Gad S; Elbakry AM
    J Pharm Pharmacol; 2024 Jun; 76(6):631-645. PubMed ID: 38507715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication, optimization, and
    Mathur P; Sharma S; Rawal S; Patel B; Patel MM
    J Liposome Res; 2020 Jun; 30(2):182-196. PubMed ID: 31060404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
    Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
    Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation.
    Rajpoot K; Jain SK
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1236-1247. PubMed ID: 28849671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer.
    Ridha AA; Kashanian S; Azandaryani AH; Rafipour R; Mahdavian E
    Curr Pharm Biotechnol; 2020; 21(4):305-315. PubMed ID: 31729941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and
    Darabi F; Saidijam M; Nouri F; Mahjub R; Soleimani M
    Biomed Res Int; 2022; 2022():6253978. PubMed ID: 35845934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin-loaded lipid nanoparticles: antitumor activity studies on MCF-7 breast cancer cells.
    Gambhire VM; Salunkhe SM; Gambhire MS
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1685-1692. PubMed ID: 29936872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.